COSTEM 2019

The 5th International Congress on Controversies in Stem Cell Transplantation and Cellular Therapies

Berlin, 24-27 October

The 5th meeting of the International Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM) was held in Berlin, Germany and brought to light a huge array of exciting updates within the transplant field, across numerous disease areas.

Explore the expansive and unique information on controversies important to stem cell transplantation and cellular therapies heard at this meeting.

View all videos

Transplantation

Post-transplant cyclophosphamide mechanisms

Christopher Kanakry • 26 Oct 2019

getITD for FLT3-ITD-based MRD monitoring in AML

Lars Bullinger • 26 Oct 2019

Optimal GVHD prophylaxis in T-cell repleted haploidentical transplantation

Christopher Kanakry • 25 Oct 2019

Is haploidentical the best curative option for sickle cell disease?

Miguel Abboud • 26 Oct 2019

GvHD

Is endothelial protection effective for GVHD, VOD and TMA?

Mohamad Mohty • 26 Oct 2019

ASCT in the outpatient setting

MRD

Improving AML outcomes

Charles Craddock

Is MRD monitoring prior to allograft standard in AML?

Michael Heuser • 25 Oct 2019

Multiple Myeloma

The Chinese CAR-T experience

Peihua Lu • 25 Oct 2019

MM: stem cell mobilization regimens with and without plerixafor

Nicolaus Kröger • 25 Oct 2019

Lymphoma

CARs: driving the field forward

Michael Bishop • 26 Oct 2019

Can CAR-T cells replace ASCT in DLBCL?

Arnon Nagler • 26 Oct 2019

Leukemia

Optimal preparative regimen for AML

Charles Craddock • 25 Oct 2019

How will CAR-T cells help us cure Ph+ ALL?

Peter Bader • 25 Oct 2019

Anemia

Cord vs. haplo in SAA

Rainer Storb • 26 Oct 2019

Aplastic anemia: treatment options in 2019

Antonio Risitano • 26 Oct 2019